Nordin BE, Roper A. Post-pregnancy osteoporosis; a syndrome? Lancet. 1955;268(6861):431–4.
Article CAS PubMed Google Scholar
2.Dunne F, Walters B, Marshall T, Heath DA. Pregnancy associated osteoporosis. Clin Endocrinol. 1993;39(4):487–90.
3.Phillips AJ, Ostlere SJ, Smith R. Pregnancy-associated osteoporosis: does the skeleton recover? Osteoporos Int. 2000;11(5):449–54. https://doi.org/10.1007/s001980070113.
Article CAS PubMed Google Scholar
4.Hong N, Kim JE, Lee SJ, Kim SH, Rhee Y. Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy- and lactation-associated osteoporosis. Clin Endocrinol. 2018;88(5):652–8. https://doi.org/10.1111/cen.13557.
5.Kyvernitakis I, Reuter TC, Hellmeyer L, Hars O, Hadji P. Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up. Osteoporos Int. 2018;29(1):135–42. https://doi.org/10.1007/s00198-017-4239-1.
Article CAS PubMed Google Scholar
6.Li LJ, Zhang J, Gao P, Lv F, Song YW, Chang XY, et al. Clinical characteristics and bisphosphonates treatment of rare pregnancy- and lactation-associated osteoporosis. Clin Rheumatol. 2018;37(11):3141–50. https://doi.org/10.1007/s10067-018-4185-0.
7.Laroche M, Talibart M, Cormier C, Roux C, Guggenbuhl P, Degboe Y. Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature. Osteoporos Int. 2017;28(11):3135–42. https://doi.org/10.1007/s00198-017-4165-2.
Article CAS PubMed Google Scholar
8.Hadji P, Boekhoff J, Hahn M, Hellmeyer L, Hars O, Kyvernitakis I. Pregnancy-associated osteoporosis: a case-control study. Osteoporos Int. 2017;28(4):1393–9. https://doi.org/10.1007/s00198-016-3897-8.
Article CAS PubMed Google Scholar
9.O'Sullivan SM, Grey AB, Singh R, Reid IR. Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int. 2006;17(7):1008–12. https://doi.org/10.1007/s00198-006-0112-3.
Article CAS PubMed Google Scholar
10.Lampropoulou-Adamidou K, Trovas G, Stathopoulos IP, Papaioannou NA. Case report: teriparatide treatment in a case of severe pregnancy- and lactation-associated osteoporosis. Hormones (Athens, Greece). 2012;11(4):495–500.
11.Stumpf UC, Kurth AA, Windolf J, Fassbender WJ. Pregnancy-associated osteoporosis: an underestimated and underdiagnosed severe disease. A review of two cases in short- and long-term follow-up. Adv Med Sci. 2007;52:94–7.
12.Jang JY, Lee JG, Jeong IK, Ahn KJ, Chung HY, Yang HI, et al. A case of post-pregnancy osteoporosis combined with ankylosing spondylitis. Rheumatol Int. 2009;29(11):1359–62. https://doi.org/10.1007/s00296-008-0820-4.
13.Allali F, Guedirra N, Hajjaj-Hassouni N. A case of post-pregnancy osteoporosis-related spinal fractures in association with ankylosing spondylitis. Clin Rheumatol. 2005;24(4):435–6. https://doi.org/10.1007/s10067-004-1074-5.
14.Tran HA, Petrovsky N. Pregnancy-associated osteoporosis with hypercalcaemia. Intern Med J. 2002;32(9–10):481–5.
Article CAS PubMed Google Scholar
15.Rillo OL, Di Stefano CA, Bermudez J, Maldonado Cocco JA. Idiopathic osteoporosis during pregnancy. Clin Rheumatol. 1994;13(2):299–304.
Article CAS PubMed Google Scholar
16.Grizzo FM, da Silva Martins J, Pinheiro MM, Jorgetti V, Carvalho MD, Pelloso SM. Pregnancy and lactation-associated osteoporosis: bone histomorphometric analysis and response to treatment with zoledronic acid. Calcif Tissue Int. 2015;97(4):421–5. https://doi.org/10.1007/s00223-015-0028-z.
Article CAS PubMed Google Scholar
17.Tanriover MD, Oz SG, Sozen T, Kilicarslan A, Guven GS. Pregnancy- and lactation-associated osteoporosis with severe vertebral deformities: can strontium ranelate be a new alternative for the treatment? Spine J. 2009;9(4):e20–4. https://doi.org/10.1016/j.spinee.2008.06.451.
18.Smith R, Athanasou NA, Ostlere SJ, Vipond SE. Pregnancy-associated osteoporosis. QJM. 1995;88(12):865–78.
19.Blanch J, Pacifici R, Chines A. Pregnancy-associated osteoporosis: report of two cases with long-term bone density follow-up. Br J Rheumatol. 1994;33(3):269–72.
Article CAS PubMed Google Scholar
20.Zhang M, Chen P, Li B, Du J, Pan T, Chen J. Approach to the patient with pregnancy and lactation-associated osteoporosis: a case report and a review of the literature. Medicine (Baltimore). 2017;96(46):e8671. https://doi.org/10.1097/MD.0000000000008671.
21.Honjo S, Mizunuma H. Changes in biochemical parameters of bone turnover and bone mineral density in post-pregnancy osteoporosis. Am J Obstet Gynecol. 2001;185(1):246–7. https://doi.org/10.1067/mob.2001.113910.
Article CAS PubMed Google Scholar
22.Anai T, Tomiyasu T, Arima K, Miyakawa I. Pregnancy-associated osteoporosis with elevated levels of circulating parathyroid hormone-related protein: a report of two cases. J Obstet Gynaecol Res. 1999;25(1):63–7.
Article CAS PubMed Google Scholar
23.Sarikaya S, Ozdolap S, Acikgoz G, Erdem CZ. Pregnancy-associated osteoporosis with vertebral fractures and scoliosis. Joint Bone Spine. 2004;71(1):84–5. https://doi.org/10.1016/j.jbspin.2003.05.003.
24.Vujasinovic-Stupar N, Pejnovic N, Markovic L, Zlatanovic M. Pregnancy-associated spinal osteoporosis treated with bisphosphonates: long-term follow-up of maternal and infants outcome. Rheumatol Int. 2012;32(3):819–23. https://doi.org/10.1007/s00296-011-1816-z.
25.Reid IR, Wattie DJ, Evans MC, Budayr AA. Post-pregnancy osteoporosis associated with hypercalcaemia. Clin Endocrinol. 1992;37(3):298–303.
26.Yeap SS, Fauzi AR, Kong NC, Halim AG, Soehardy Z, Rahimah I, et al. A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus. J Rheumatol. 2008;35(12):2344–7. https://doi.org/10.3899/jrheum.080634.
Article CAS PubMed Google Scholar
27.Fuleihan Gel H, Salamoun M, Mourad YA, Chehal A, Salem Z, Mahfoud Z, et al. Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trial. J Clin Endocrinol Metab. 2005;90(6):3209–14. https://doi.org/10.1210/jc.2004-1444.
28.Minsker DH, Manson JM, Peter CP. Effects of the bisphosphonate, alendronate, on parturition in the rat. Toxicol Appl Pharmacol. 1993;121(2):217–23. https://doi.org/10.1006/taap.1993.1148.
Article CAS PubMed Google Scholar
29.Levy S, Fayez I, Taguchi N, Han JY, Aiello J, Matsui D, et al. Pregnancy outcome following in utero exposure to bisphosphonates. Bone. 2009;44(3):428–30. https://doi.org/10.1016/j.bone.2008.11.001.
Article CAS PubMed Google Scholar
30.Cohen A. Premenopausal osteoporosis. Endocrinol Metab Clin N Am. 2017;46(1):117–33. https://doi.org/10.1016/j.ecl.2016.09.007.
31.Cohen A, Stein EM, Recker RR, Lappe JM, Dempster DW, Zhou H, et al. Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study. J Clin Endocrinol Metab. 2013;98(5):1971–81. https://doi.org/10.1210/jc.2013-1172.
Article CAS PubMed PubMed Central Google Scholar
32.Fazeli PK, Wang IS, Miller KK, Herzog DB, Misra M, Lee H, et al. Teriparatide increases bone formation and bone mineral density in adult women with anorexia nervosa. J Clin Endocrinol Metab. 2014;99(4):1322–9. https://doi.org/10.1210/jc.2013-4105.
Article CAS PubMed PubMed Central Google Scholar
33.Choe EY, Song JE, Park KH, Seok H, Lee EJ, Lim SK, et al. Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures. J Bone Miner Metab. 2012;30(5):596–601. https://doi.org/10.1007/s00774-011-0334-0.
Article CAS PubMed Google Scholar
34.Polat SB, Evranos B, Aydin C, Cuhaci N, Ersoy R, Cakir B. Effective treatment of severe pregnancy and lactation-related osteoporosis with teriparatide: case report and review of the literature. Gynecol Endocrinol. 2015;31(7):522–5. https://doi.org/10.3109/09513590.2015.1014787.
35.Coskun Benlidayi I, Sarpel T, Guzel R. Short-term treatment experience with teriparatide in pregnancy- and lactation-associated osteoporosis. J Obstet Gynaecol. 2014;34(8):736. https://doi.org/10.3109/01443615.2014.920800.
Article CAS PubMed Google Scholar
36.Hellmeyer L, Boekhoff J, Hadji P. Treatment with teriparatide in a patient with pregnancy-associated osteoporosis. Gynecol Endocrinol. 2010;26(10):725–8. https://doi.org/10.3109/09513591003649831.
Article CAS PubMed Google Scholar
37.Ijuin A, Yoshikata H, Asano R, Tsuburai T, Kikuchi R, Sakakibara H. Teriparatide and denosumab treatment for pregnancy and lactation-associated osteoporosis with multiple vertebral fractures: a case study. Taiwan J Obstet Gynecol. 2017;56(6):863–6. https://doi.org/10.1016/j.tjog.2017.10.028.
38.Cohen A, Kamanda-Kosseh M, Recker RR, Lappe JM, Dempster DW, Zhou H, et al. Bone density after teriparatide discontinuation in premenopausal idiopathic osteoporosis. J Clin Endocrinol Metab. 2015;100(11):4208–14. https://doi.org/10.1210/jc.2015-2829.
Article CAS PubMed PubMed Central Google Scholar
39.Tsuchie H, Miyakoshi N, Hongo M, Kasukawa Y, Ishikawa Y, Shimada Y. Amelioration of pregnancy-associated osteoporosis after treatment with vitamin K(2): a report of four patients. Ups J Med Sci. 2012;117(3):336–41. https://doi.org/10.3109/03009734.2012.676573.
Comments (0)